Does UnitedHealthcare Cover Armour Thyroid?

How UnitedHealthcare Classifies Armour Thyroid on Its Formulary

UnitedHealthcare places Armour Thyroid on Tier 3 in most of its commercial formularies, which means higher copays than Tier 1 generics like levothyroxine. The exact copay depends on your specific plan design, but Tier 3 drugs typically carry a $50 to $90 copay or 30% to 50% coinsurance after the deductible.

You can verify your plan's formulary placement by logging into myuhc.com and searching "desiccated thyroid" or "Armour Thyroid" in the drug lookup tool. Formulary documents update quarterly, and a drug's tier can shift at renewal. Plans sold through the Health Insurance Marketplace (ACA exchange plans) may list Armour Thyroid on Tier 2 in some states, while employer-sponsored self-funded plans sometimes exclude it entirely.

UnitedHealthcare's pharmacy benefit manager, Optum Rx, administers claims for most UHC members. When your pharmacist submits the claim, the system checks two things: (1) whether the drug is on your plan's formulary, and (2) whether the prior authorization flag has been satisfied. If either check fails, the claim rejects at the point of sale. A rejected claim is not the same as a denial of coverage. It means the administrative prerequisites have not yet been met.

The American Thyroid Association (ATA) 2014 guidelines recommend levothyroxine monotherapy as standard first-line treatment for hypothyroidism, which is the clinical rationale insurers use for requiring step therapy through levothyroxine before approving desiccated thyroid products.

Prior Authorization Requirements for Armour Thyroid

UnitedHealthcare requires prior authorization for Armour Thyroid on the majority of its commercial plans. The PA process exists because UHC considers levothyroxine the first-line standard of care.

To obtain PA approval, your prescriber typically needs to document one of the following: (a) you tried levothyroxine at an adequate dose for at least 6 to 12 weeks and did not achieve symptom control despite normal TSH, (b) you experienced adverse effects on levothyroxine that warranted discontinuation, or (c) you have a documented medical reason levothyroxine is contraindicated. Some plans also accept documentation that you were stable on Armour Thyroid before enrolling in UnitedHealthcare.

Your prescriber submits the PA request to Optum Rx by phone, fax, or through the CoverMyMeds electronic portal. Standard requests receive a decision within 72 hours. If your physician indicates clinical urgency, an expedited review must be completed within 24 hours under federal and state utilization review requirements.

A 2013 crossover trial by Hoang et al. (N=70) published in the Journal of Clinical Endocrinology & Metabolism found that 49% of patients preferred desiccated thyroid extract over levothyroxine, with a mean weight loss of 2.86 pounds on DTE versus levothyroxine, despite no difference in TSH levels between groups (Hoang et al., 2013) [1]. This trial is one of the few randomized comparisons prescribers can cite in a PA letter to support the switch.

Step Therapy: What UnitedHealthcare Expects Before Approval

Step therapy is the formal name for the "try this first" requirement. UnitedHealthcare's step therapy protocol for Armour Thyroid almost always requires a documented trial of levothyroxine.

The typical step therapy sequence works like this. First, you are prescribed generic levothyroxine (Synthroid equivalent) for a minimum of 6 to 12 weeks. Your TSH is rechecked, and if levels normalize but hypothyroid symptoms persist (fatigue, weight gain, cognitive sluggishness, hair thinning), your prescriber documents the incomplete response. That documentation becomes the basis for requesting Armour Thyroid as a step-two agent.

Some UnitedHealthcare plans also accept a trial of Tirosint (levothyroxine gel cap) or liothyronine (synthetic T3) before approving desiccated thyroid. The logic from UHC's pharmacy and therapeutics committee is that synthetic combinations of T4 plus T3 are more standardized than porcine-derived preparations, a position the ATA echoed in its 2014 guidelines while acknowledging that some patients do report preference for DTE [2].

If you were already taking Armour Thyroid before your UHC plan started, ask your prescriber to submit a "continuation of therapy" exception rather than going through step therapy from scratch. Optum Rx has a specific exception pathway for members who switch insurers mid-treatment. This can bypass the levothyroxine trial requirement entirely if chart notes show at least 90 days of stable therapy on Armour Thyroid.

One practical tip: keep copies of your prior lab results showing TSH, free T4, and free T3 while on levothyroxine and while on Armour Thyroid. Objective lab comparisons strengthens any PA or appeal submission.

What Armour Thyroid Costs on a UnitedHealthcare Plan

The out-of-pocket cost for Armour Thyroid on a UnitedHealthcare plan depends on your tier placement, deductible status, and whether your plan uses copays or coinsurance.

On a typical Tier 3 copay plan, expect $50 to $90 per 30-day fill. On coinsurance plans, the cost is usually 30% to 50% of the negotiated price after meeting the deductible. The manufacturer list price runs approximately $180 per month for common doses (60 mg or 90 mg tablets). Cash-pay pricing at retail pharmacies averages about $85 per month when using discount cards like GoodRx or RxSaver, which sometimes undercuts the insured copay on high-deductible plans.

Allergan (now AbbVie) has offered manufacturer savings cards for Armour Thyroid in the past, but these coupons generally cannot be applied to government-funded plans (Medicare Part D, Medicaid, Tricare). On commercial UnitedHealthcare plans, manufacturer copay cards can typically reduce the Tier 3 copay to $25 to $40, though the card terms change annually. Check the Armour Thyroid brand website or ask your pharmacy if a current savings card is active.

For members on UnitedHealthcare Medicare Advantage plans, Armour Thyroid coverage varies more widely. Some MA-PD plans do not list desiccated thyroid products at all, while others place it on Tier 3 or Tier 4. The Medicare Plan Finder tool is the most reliable way to verify formulary status for MA plans.

Mail-order pharmacy through Optum Rx can offer savings of 10% to 20% per fill for 90-day supplies compared to retail 30-day pricing. Your plan's prescription drug schedule of benefits will specify whether mail-order is available and at what copay differential.

How to Appeal a UnitedHealthcare Denial of Armour Thyroid

If UnitedHealthcare denies your prior authorization or the claim is rejected after step therapy, you have the right to a two-level internal appeal followed by an external review.

The first-level internal appeal must be filed within 180 days of the denial. Your prescriber should submit a letter of medical necessity explaining why Armour Thyroid is required for your specific clinical situation. Strong appeals include: documented levothyroxine trial dates and lab results, a record of persistent symptoms on levothyroxine, and citations from peer-reviewed literature supporting DTE use. The Hoang et al. 2013 trial is useful here [1], as is the 2020 European Thyroid Association survey that found 33.3% of hypothyroid patients reported dissatisfaction with levothyroxine monotherapy (Winther et al., Eur Thyroid J, 2020) [3].

UnitedHealthcare must respond to first-level appeals within 30 calendar days for standard requests (72 hours for urgent). If the first appeal is denied, you can request a second-level internal appeal with additional supporting documentation. If both internal appeals fail, federal law under the Affordable Care Act guarantees your right to an external review by an independent review organization (IRO) that has no financial relationship with UnitedHealthcare. The IRO's decision is binding on UHC.

Dr. Antonio Bianco, a professor of medicine at the University of Chicago and former president of the American Thyroid Association, has stated: "A subset of hypothyroid patients do not feel well on levothyroxine alone, and this is an area where we need more clinical trials and greater physician autonomy in prescribing." This perspective, published in multiple interviews and reflected in the ATA research agenda, supports appeal arguments centered on individualized therapy [2].

File all appeals in writing, keep copies of every submission, and note the UHC reference number for each interaction. If your employer self-funds the plan, the appeal goes through UHC's administrative process but the final coverage decision may rest with the employer's plan administrator.

Armour Thyroid vs. Levothyroxine: Why Insurers Prefer Levothyroxine

UnitedHealthcare's formulary preference for levothyroxine is driven by three factors: cost, standardization, and guideline alignment.

Generic levothyroxine costs $4 to $15 per month. Armour Thyroid costs 6 to 12 times more. From a pharmacy benefit management standpoint, the cost differential is significant across a population.

Levothyroxine contains only synthetic T4 (thyroxine), which the body converts to T3 (triiodothyronine) through peripheral deiodinase enzymes. Armour Thyroid contains both T4 and T3 derived from porcine thyroid glands, at a fixed T4:T3 ratio of approximately 4.2:1. The human thyroid secretes T4 and T3 at a ratio closer to 14:1, meaning desiccated thyroid delivers a supraphysiological proportion of T3 relative to natural human secretion (Jonklaas et al., Thyroid, 2014) [4].

The clinical significance of this ratio difference remains debated. A 2018 systematic review in the Journal of Clinical Endocrinology & Metabolism analyzed 13 RCTs comparing DTE or T4+T3 combination therapy to T4 monotherapy and found no consistent superiority of combination therapy on quality-of-life measures, though individual patient preference for DTE was documented in several trials (Defined by protocol: Feller et al., 2018) [5]. The ATA's 2014 guidelines acknowledged that a trial of DTE may be considered in patients who do not feel well on levothyroxine, but stopped short of recommending it as a routine first-line option [2].

For prescribers seeking PA approval, framing the request around persistent patient symptoms despite adequate levothyroxine dosing, with objective labs showing normal TSH and low-normal free T3, tends to be the most successful strategy with UHC.

Tips for Getting Armour Thyroid Covered by UnitedHealthcare

Getting Armour Thyroid covered requires preparation from both you and your prescriber. These steps improve approval rates.

Before your appointment, collect all lab records from your levothyroxine treatment period. You need TSH, free T4, and free T3 values at each dose adjustment. A pattern of normal TSH with low free T3 and ongoing symptoms is the strongest clinical argument for switching to a T4/T3 combination product like Armour Thyroid.

Ask your prescriber to use the CoverMyMeds portal for electronic PA submission, which is faster than fax. The PA form should include your specific diagnosis code (E03.9 for hypothyroidism, unspecified), the dates and doses of your levothyroxine trial, relevant lab values, and a brief clinical rationale. Mentioning the Hoang et al. 2013 trial data [1] adds weight.

If cost is the primary barrier and PA is denied, ask about NP Thyroid (generic desiccated thyroid by Acella Pharmaceuticals). Some UnitedHealthcare formularies list NP Thyroid on a lower tier than Armour Thyroid because its average wholesale price is lower. The active ingredient is identical: porcine desiccated thyroid, USP. The FDA requires that all marketed desiccated thyroid products meet the same USP potency standards for T4 and T3 content per grain [6].

For high-deductible health plans (HDHPs) paired with a health savings account (HSA), compare the cash-pay price at pharmacies using discount tools against your insured cost after the deductible. In some cases, paying cash at $85 per month is cheaper than applying the $180 list price toward a $3,000 deductible.

UnitedHealthcare Medicare Advantage and Armour Thyroid

Medicare Advantage (MA) plans administered by UnitedHealthcare follow different formulary rules than commercial plans. Coverage for Armour Thyroid on MA plans varies by region and plan year.

Under Medicare Part D, all plans must cover at least two drugs per therapeutic class. Thyroid agents are a broad class, and most Part D formularies satisfy this requirement with levothyroxine and liothyronine, not necessarily with desiccated thyroid products. Armour Thyroid may appear on some UHC MA-PD formularies but is frequently placed on Tier 3 or excluded entirely.

If your UnitedHealthcare Medicare Advantage plan does not list Armour Thyroid, you can request a formulary exception. The process parallels the commercial PA pathway: your prescriber must demonstrate medical necessity and prior treatment failure on formulary alternatives. Medicare Part D exception requests have a 72-hour standard timeline and 24-hour expedited timeline, with appeal rights that extend to the Medicare Appeals Council and federal court if needed (CMS Medicare Managed Care Manual, Ch. 18) [7].

The 2023 ATA presidential task force report noted that access to thyroid hormone preparation options remains inconsistent across payer formularies and called for greater transparency in formulary coverage decisions for thyroid drugs [8]. This ongoing professional society advocacy may influence future formulary placement decisions.